Effective August 15, Blueprint Genetics will transition laboratory services to our global headquarters and laboratory in Helsinki, Finland and discontinue providing lab services from the US.
From August 15, we can only accept orders from you with institutional billing. If you wish to continue doing business with Blueprint Genetics, please fill out the request form below to have your laboratory services agreement (LSA) amended, acknowledging that your samples will be processed in Helsinki, Finland and that Blueprint Genetics will bill you according to our institutional billing practices, in US dollars. Upon receipt of this form, our team will contact you to create or amend your laboratory services agreement with Blueprint Genetics.
Please note: As of July 26, 2024, the My Retina Tracker® program will no longer be available. All orders must be submitted in Nucleus on or before 11:59 pm EST July 25, 2024. Please ensure patient samples and consent forms arrive at Blueprint Genetics no later than August 16, 2024.
Laboratory Services Agreement Amendment Request Form
"*" indicates required fields
Blueprint Genetics will continue to offer genetic test services for you and other US based customers through our Helsinki lab. Our Helsinki laboratory is our largest facility where we service clients worldwide and a location where we can centralize innovation and expertise. All samples received at our US lab after August 15th, with the client’s permission, will be forwarded, processed, and resulted from our laboratory in Helsinki, Finland.
US Lab Address
Once we have created or amended your LSA, samples can continue to be sent to our US laboratory at:
Blueprint Genetics
200 Forest Street, 2nd floor
Marlborough, MA 01752
Contact Information
You will continue to be supported by our US Client Services team: